Skip to content
  • Home
  • Project
  • Partners
  • News
  • Events
  • Publications
  • Contact
  • Intranet

Publications

Brain tumour meeting 2024
11.06.2024
Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer
04.06.2024
Genotoxicity and heating Performance of VxFe3-xO4 nanoparticles in Health applications
04.06.2024
Adverse (geno)toxic effects of bisphenol A and its analogues in hepatic 3D cell model
04.06.2024
Combined Toxic Effects of BPA and Its Two Analogues BPAP and BPC in a 3D HepG2 Cell Model
04.06.2024
Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo
04.06.2024
Joyful New year. May year 2024 be a year of wonder and new discoveries.
19.12.2023
Innovative Probes of Metalloproteases 2 and 9 for Targeting Brain Tumor Glioblastoma
22.09.2023
Chemotherapy affects the metabolism of glioblastoma stem cells differently than glioblastoma differentiated cells
22.09.2023
Personalized in vitro glioblastoma models for evaluation of therapy response and resistance
14.07.2023
←123→

Discover More About the Project

The overarching aim of CutCancer is to improve the scientific excellence and innovation capacity in the field of 3D in vitro cancer research at the National Institute of Biology, Slovenia.

Discover methodology

Twinning for excellence to strategically advance research in carcinogenesis and cancer.

  • Home
  • Project
  • Partners
  • Events
  • Publications
  • Contact
eu-logo

This project has received funding from the European Union’s Horizon Europe Research and Innovation Program under Grant Agreement No 101079113 and the UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee under Grant No 10050740.

uk-research-logo
© 2023 Cut Cancer. All rights reserved.
Terms & conditions
Contact
Go to Top
  • Home
  • Project
  • Partners
  • News
  • Events
  • Publications
  • Contact
  • Intranet